Letter to the Editor Regarding "Utilization and Cost Implications of Hematopoietic Progenitor Cells Stored for a Future Salvage Autologous Transplantation or Stem Cell Boost in Myeloma Patients"

Transplant Cell Ther. 2021 Mar;27(3):199-200. doi: 10.1016/j.jtct.2020.11.010. Epub 2020 Dec 14.

Authors

Julia Wolf¹, Jon Smythe², James Griffin³

Affiliations

¹ National Health Service Blood and Transplant, Filton, United Kingdom; Bristol Haematology and Oncology Centre, Bristol, United Kingdom. Electronic address: julia.wolf@nhsbt.nhs.uk.
² National Health Service Blood and Transplant, Oxford, United Kingdom.
³ National Health Service Blood and Transplant, Filton, United Kingdom; Bristol Haematology and Oncology Centre, Bristol, United Kingdom.

PMID: 35348115
DOI: 10.1016/j.jtct.2020.11.010

No abstract available

Publication types

Letter
Comment

MeSH terms

Hematopoietic Stem Cells
Humans
Multiple Myeloma* / therapy
Salvage Therapy
Transplantation, Autologous